Research programme: kinesin spindle protein inhibitors - Cytokinetics/GlaxoSmithKline

Drug Profile

Research programme: kinesin spindle protein inhibitors - Cytokinetics/GlaxoSmithKline

Alternative Names: GSK-295; KSPA-1

Latest Information Update: 28 Jan 2009

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Cytokinetics
  • Developer Cytokinetics; GlaxoSmithKline
  • Class Small molecules
  • Mechanism of Action KIF11 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 30 Sep 2008 Discontinued - Preclinical for Cancer in USA (unspecified route)
  • 01 Sep 2008 Interim pharmacokinetics data from a preclinical trial in Cancer presented at the 236th American Chemical Society National Meeting (236th-ACS-2008)
  • 19 Jun 2008 Cytokinetics and GlaxoSmithKline extend their collaboration for a third time
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top